Navigating the shifts of perimenopause can bring new experiences, and for many women, managing stress becomes a significant focus. Adaptogens are a class of botanicals that may help the body adapt to various stressors, and two popular options often discussed are Rhodiola rosea and Ashwagandha (Withania somnifera).
Understanding the potential differences between these two adaptogens may help you consider which might be more aligned with your individual needs during this transitional life stage. This article aims to provide an evidence-based overview of Rhodiola and Ashwagandha, focusing on their potential roles in supporting well-being.
Understanding Adaptogens: A General Overview
Adaptogens are substances, often from plants, that are believed to help the body maintain balance by supporting its ability to adapt to physical, chemical, and biological stress. They are thought to normalize bodily functions, regardless of the initial state, and are generally considered to have a broad range of effects rather than targeting a specific system [1].
The concept of adaptogens has roots in traditional medicine systems and has gained attention in modern wellness discussions. While their mechanisms of action can be complex and are still being researched, the general idea is that they help the body build resilience to various stressors that can impact overall well-being. This can be particularly relevant during periods of hormonal fluctuation, such as perimenopause, where the body may experience additional demands.
Rhodiola Rosea: Potential Support for Fatigue and Mental Performance
Rhodiola rosea, sometimes known as ‘golden root,’ is an adaptogen traditionally used in Eastern European and Asian medicine. It is often considered for its potential to support energy levels and mental clarity, especially in situations involving fatigue or demanding mental tasks. While specific studies on Rhodiola’s effects during perimenopause are limited, its general adaptogenic properties suggest it may play a role in supporting the body‘s response to stress.
Research has explored Rhodiola’s potential in relation to various aspects of stress and fatigue. It is thought to influence neurotransmitter activity and energy metabolism, which could contribute to its perceived benefits. When considering Rhodiola, it’s important to be aware that the specific compounds, such as rosavins and salidrosides, are often standardized in extracts, and their concentrations can vary between products. The evidence base for Rhodiola’s effects on women in midlife specifically is still developing, and individual responses can vary.
Ashwagandha: Exploring its Anxiolytic and Stress-Reducing Potential
Ashwagandha (Withania somnifera) is a well-known herb in Ayurvedic medicine, where it has been used for centuries. It is often recognized for its potential anxiolytic (anxiety-reducing) properties and its role in supporting the body’s stress response. Ashwagandha contains compounds called withanolides, which are believed to be responsible for many of its observed effects.
Several studies have investigated Ashwagandha’s potential in relation to stress and anxiety. For instance, a double-blind, randomized, placebo-controlled clinical study found adaptogenic and anxiolytic effects of Ashwagandha root extract in healthy adults [2]. Another study explored its use as an add-on therapy for patients with COPD, suggesting potential benefits for well-being [3]. While these studies were not specifically on perimenopausal women, the findings contribute to the understanding of Ashwagandha’s general adaptogenic and calming properties. There is also research exploring different formulations of Ashwagandha for improved bioavailability [4].
Ashwagandha is often perceived as having a more ‘calming’ or ‘grounding’ effect compared to Rhodiola, which some find to be more ‘energizing.’ This distinction can be a factor for women deciding between the two, particularly if managing feelings of agitation or difficulty relaxing is a primary concern during perimenopause.
Rhodiola vs. Ashwagandha: Key Considerations for Perimenopause Stress
When considering rhodiola vs ashwagandha for navigating stress during perimenopause, it can be helpful to think about your primary concerns. If you are experiencing feelings of fatigue, mental fogginess, or difficulty concentrating, Rhodiola might be an area to explore for its potential to support energy and mental performance. Its historical use often aligns with supporting resilience during demanding periods.
Conversely, if feelings of tension, difficulty relaxing, or general unease are more prominent, Ashwagandha might be considered due to its documented adaptogenic and anxiolytic properties [2]. Its traditional use often points towards supporting a sense of calm and balance. It’s important to remember that individual responses to adaptogens can vary significantly, and what works well for one person may not be the same for another.
The evidence base for both Rhodiola and Ashwagandha is growing, but specific research directly on perimenopausal women is still developing. Both are generally considered adaptogens, meaning they aim to help the body adapt to various stressors [1]. The choice between them may ultimately come down to individual preference and the specific types of stress you are aiming to address. Some individuals may even consider alternating or combining them under appropriate guidance, though more research is needed on such approaches.
References
- A preliminary review of studies on adaptogens: comparison of their bioactivity in TCM with that of ginseng-like herbs used worldwide. Chinese medicine, 2018
- Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study. Cureus, 2019
- Withania somnifera (L.) Dunal as Add-On Therapy for COPD Patients: A Randomized, Placebo-Controlled, Double-Blind Study. Frontiers in pharmacology, 2022
- Superior Bioavailability of a Novel 1.5% Ashwagandha Formulation (Zenroot™): A Randomized, Double-Blind, Single-Dose, Comparative, Oral Bioavailability Study in Healthy Adults. Advances in therapy, 2025
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
